Position in JNJ
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$16,033,126
+$1,896,184 QoQ
Shares Held
63,130
+9.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
#851
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Smith Salley Wealth Management holds $107,302,312 across 8 Drug Manufacturers - General names. JNJ ranks #3 (14.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
159,074 | $40,029,381 | |
| 2 | LLY |
ELI LILLY & Co
|
23,731 | $28,463,675 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
63,130 | $16,033,126 | |
| 4 | AZN |
Astrazeneca PLC
|
61,200 | $11,604,744 | |
| 5 | MRK |
Merck & Co., Inc.
|
45,198 | $5,807,943 | |
| 6 | AMGN |
Amgen Inc
|
11,307 | $4,094,490 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
11,437 | $658,999 | |
| 8 | NVS |
Novartis AG
|
3,892 | $609,954 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,033,126 | 63,130 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $14,136,942 | 57,834 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $11,502,694 | 55,582 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $9,536,150 | 51,430 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $7,018,404 | 45,947 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $7,376,231 | 44,478 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $6,408,546 | 44,313 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $7,305,826 | 45,081 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $6,334,282 | 43,338 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $6,889,807 | 43,554 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $9,244,367 | 58,979 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $9,487,199 | 60,913 | Shares | Other | 2023-10-27 | |
| 2023-06-30 | $10,114,927 | 61,110 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $9,419,195 | 60,769 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $10,543,708 | 59,687 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $8,225,828 | 50,354 | Shares | Other | 2022-11-01 | |
| 2022-06-30 | $8,789,406 | 49,515 | Shares | Other | 2022-08-01 | |
| 2022-03-31 | $7,865,466 | 44,380 | Shares | Other | 2022-05-10 | |
| 2021-12-31 | $7,523,829 | 43,981 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $7,143,306 | 44,231 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $7,171,625 | 43,533 | Shares | Other | 2021-08-09 | |
| 2021-03-31 | $7,090,387 | 43,142 | Shares | Other | 2021-04-30 | |
| 2020-12-31 | $6,451,949 | 40,996 | Shares | Other | 2021-01-28 | |
| 2020-09-30 | $6,049,291 | 40,632 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $5,705,780 | 40,573 | Shares | Other | 2020-08-04 | |
| 2020-03-31 | $5,197,206 | 39,634 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||